Inventor · disambiguated record
Louie Daniel Garcia
Also filed as: GARCIA LOUIE D · GARCIA LOUIE DANIEL
19 granted patents·4 pending applications·221 citations·filing 2010–2022
95Inventor score
Top patents by PatentIndex Score
23 records- 0198US11357727B1Manufacturing of bupivacaine multivesicular liposomesPACIRA PHARMACEUTICALS INC·Filed 2021·Granted Jun 14, 2022·23 cites·32 claims
- 0298US11311486B1Manufacturing of bupivacaine multivesicular liposomesPACIRA PHARMACEUTICALS INC·Filed 2021·Granted Apr 26, 2022·24 cites·34 claims
- 0398US11304904B1Manufacturing of bupivacaine multivesicular liposomesPACIRA PHARMACEUTICALS INC·Filed 2021·Granted Apr 19, 2022·24 cites·35 claims
- 0498US11278494B1Manufacturing of bupivacaine multivesicular liposomesPACIRA PHARMACEUTICALS INC·Filed 2021·Granted Mar 22, 2022·24 cites·60 claims
- 0598US11185506B1Manufacturing of bupivacaine multivesicular liposomesPACIRA PHARMACEUTICALS INC·Filed 2021·Granted Nov 30, 2021·22 cites·17 claims
- 0698US11179336B1Manufacturing of bupivacaine multivesicular liposomesPACIRA PHARMACEUTICALS INC·Filed 2021·Granted Nov 23, 2021·28 cites·20 claims
- 0798US11033495B1Manufacturing of bupivacaine multivesicular liposomesPACIRA PHARMACEUTICALS INC·Filed 2021·Granted Jun 15, 2021·34 cites·22 claims
- 0892US10709665B2Zinc meloxicam complex microparticle multivesicular liposome formulations and processes for making the samePACIRA PHARMACEUTICALS INC·Filed 2017·Granted Jul 14, 2020·10 cites·34 claims
- 0992US10617642B2Sustained release formulation of a non-steroidal anti-inflammatory drugPACIRA PHARMACEUTICALS INC·Filed 2013·Granted Apr 14, 2020·9 cites·20 claims
- 1088US11040011B2Zinc meloxicam complex microparticle multivesicular liposome formulations and processes for making the samePACIRA PHARMACEUTICALS INC·Filed 2020·Granted Jun 22, 2021·2 cites·6 claims
- 1184US10729651B2Sustained release formulation of a non-steroidal anti-inflammatory drugPACIRA PHARMACEUTICALS INC·Filed 2013·Granted Aug 4, 2020·2 cites·14 claims
- 1283US10675245B2Sustained release formulation of a non-steroidal anti-inflammatory drugPACIRA PHARMACEUTICALS INC·Filed 2013·Granted Jun 9, 2020·2 cites·19 claims
- 1382US9770414B2Sustained release formulation of methotrexate as a disease-modifying antirheumatic drug (DMARD) and an anti-cancer agentGARCIA LOUIE DANIEL·Filed 2010·Granted Sep 26, 2017·13 cites·65 claims
- 1477US10123974B2Sustained release formulation of a non-steroidal anti-inflammatory drugPACIRA PHARMACEUTICALS INC·Filed 2013·Granted Nov 13, 2018·2 cites·14 claims
- 1577US9974744B2Sustained release formulation of a non-steroidal anti-inflammatory drugPACIRA PHARMACEUTICALS INC·Filed 2013·Granted May 22, 2018·2 cites·20 claims
- 1661US10610486B2Sustained release formulation of a non-steroidal anti-inflammatory drugGARCIA LOUIE DANIEL·Filed 2011·Granted Apr 7, 2020·0 cites·19 claims
- 1759US12285419B2Bupivacaine multivesicular liposome formulations and uses thereofPACIRA PHARMACEUTICALS INC·Filed 2022·Granted Apr 29, 2025·0 cites·38 claims
- 1859US12285435B2Multivesicular liposome formulations of dexamethasonePACIRA PHARMACEUTICALS INC·Filed 2022·Granted Apr 29, 2025·0 cites·22 claims
- 1953US2021322316A1Zinc meloxicam complex microparticles and anesthetic formulations and processes for making the samePACIRA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2052US2022233446A1Manufacturing of bupivacaine multivesicular liposomesPACIRA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2151US10028911B2Sustained release formulation of methotrexate as a disease-modifying antirheumatic drug (DMARD) and an anti-cancer agentPACIRA PHARMACEUTICALS INC·Filed 2013·Granted Jul 24, 2018·0 cites·24 claims
- 2250US2022273568A1Multivesicular liposome formulations of dexmedetomidinePACIRA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2340US2016206580A1Multivesicular liposome formulations of tranexamic acidPACIRA PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Louie Daniel Garcia files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →